Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily
Read More
Biotech and Pharmaceuticals
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant
Read More
Alzheimer’s drug Leqembi promises to give patients more time, but they face a long road to treatment
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties, diagnostic test requirements and regular brain scans, among others.
Read More
What is mpox and why has the WHO declared it a public health emergency?
Here's what we know about the latest mpox outbreak. Source link
Read More
Bavarian Nordic shares pop over 11% on earnings beat, bumper mpox vaccine order
Shares of Danish biotech company Bavarian Nordic jumped in early deals Thursday after reporting first-half earnings and a bumper mpox
Read More
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Sesame is offering compounded semaglutide — the active ingredient in Wegovy and Ozempic — to help users access obesity and
Read More
Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial
The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period. Source
Read More
Here’s why Walgreens and CVS retail pharmacies are struggling — and what they’re doing to fix it
Drugstores remain an important fixture of the U.S. health-care system that tens of millions of Americans rely on, but they
Read More
Bayer shares soar 11% after key U.S. legal win against Roundup cancer claims
Bayer shares rose as the company said it scored a legal victory in its suit over claims that exposure to
Read More